|1.||Tamura, Kouichi: 2 articles (02/2006 - 02/2005)|
|2.||Chida, Noboru: 2 articles (02/2006 - 02/2005)|
|3.||Sudo, Yuji: 2 articles (02/2006 - 02/2005)|
|4.||Kukita, Kazuma: 1 article (11/2007)|
|5.||Meguro, Makoto: 1 article (11/2007)|
|6.||Katsuramaki, Tadashi: 1 article (11/2007)|
|7.||Mizuguchi, Toru: 1 article (11/2007)|
|8.||Isobe, Masato: 1 article (11/2007)|
|9.||Kikuchi, Hitoshi: 1 article (11/2007)|
|10.||Taketani, Sonofu: 1 article (11/2007)|
11/01/2007 - "The present study demonstrates that FR260330 reduces liver fibrosis by the inhibition of transforming growth factor-beta1 and retards the development of cirrhosis. "
11/01/2007 - "After 12 weeks of treatment with FR260330, the rats showed inhibition of progressions of cirrhosis, ascites, and splenomegaly as well as a significant reduction in the proportions of connective tissue in the liver. "
|4.||Liver Cirrhosis (Hepatic Cirrhosis)
02/27/2006 - "In this study, the effect of FR260330 in the prevention of renal I/R injury was evaluated in the model of one kidney ischemia in Vervet monkeys. "
02/27/2006 - "Transient (60 min) left renal ischemia was produced by simultaneous contralateral nephrectomy in treated (FR260330 20 mg/kg/day) and placebo control groups. "
|1.||Nitric Oxide (Nitrogen Monoxide)
|2.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)